CION Cancer Clinics
Risk-reducing surgery: operating before cancer happens | CION Cancer Clinics
Risk-reducing surgery removes a healthy organ before cancer can start in it. It is offered only when an inherited gene fault, or a very strong family pattern, makes cancer in that organ far more likely than usual. This page explains which operations exist, how a family gets from a worry to a decision, and what the surgery cannot do. It will not tell you what to choose. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- What is risk-reducing surgery?
- Which organs are removed, and for which gene faults?
- How does a person get from a family history to an operation?
- Surgery now, or close watching instead?
- Four things families tell us, and what is actually true
- Who is this not for, and what can this page not tell you?
- Common questions about risk-reducing surgery
The short answer
What is risk-reducing surgery?
Risk-reducing surgery removes a healthy organ before cancer has started in it, because the chance of cancer starting there is unusually high. It is offered to a small group of people, almost always after a genetic test has shown an inherited fault that makes cancer in that organ likely.
Why anyone would operate on a healthy organ
Most people carry an ordinary, low lifetime chance of any one cancer. A person who has inherited a faulty gene such as BRCA1, BRCA2, CDH1 or a Lynch syndrome gene carries a much higher chance, often at a younger age. Removing the organ where that cancer would start lowers the chance sharply. Nothing else lowers it as far. That is the whole argument, and it only holds when the starting risk is high.
What it is not
It is not an operation for a cancer that has already been found. That is treatment surgery, and it follows different rules. It is also not offered because a relative had cancer, on its own. A family history is the reason to be assessed. The assessment, and usually a gene test, decides whether surgery is even on the table.
Nobody on this page will tell you what to choose. That decision belongs to you and the team who know your test result, your age and your family.The operations
Which organs are removed, and for which gene faults?
Each operation is tied to a specific inherited risk. A gene fault that raises the chance of one cancer does not mean every organ is at risk.
Breasts
Both breasts are removed, usually with the option of rebuilding them in the same operation. Offered mainly to people with a BRCA1 or BRCA2 fault, and to some with a very strong family history.
Ovaries and tubes
Both ovaries and both fallopian tubes are removed, most often by keyhole surgery. Offered to BRCA and some Lynch syndrome carriers once childbearing is complete. It brings on the menopause.
Womb
Discussed with women who carry a Lynch syndrome gene fault, where womb cancer is one of the commonest risks. Often done together with the ovaries and tubes.
Stomach
The whole stomach is removed in families with a CDH1 fault, because the cancer it causes grows in a scattered way that scopes cannot see early. It is a major operation with lifelong changes to eating.
Large bowel
Most or all of the colon is removed in familial adenomatous polyposis (FAP), where hundreds of polyps form and some will turn into cancer if left.
Thyroid
The thyroid gland is removed in children and adults with a RET gene fault (MEN2), often at a young age, because the cancer it causes can start early in life.
Not sure whether this applies to you?
Ask an oncologistThe pathway
How does a person get from a family history to an operation?
-
Someone notices a pattern
Several relatives with the same cancer, cancers at an unusually young age, or one person with two separate cancers. Often it is a treating oncologist who raises it after a relative's diagnosis.
-
Genetic counselling
A counsellor or geneticist draws the family tree, explains what a test could and could not show, and asks whether you want it. You can say no at this stage.
-
The gene test
A blood or saliva sample. Where possible the relative who had cancer is tested first, because their result tells the family which fault to look for.
-
The result meeting
The result is explained in person. A fault found is not a diagnosis of cancer. It is a statement about chance, and it is where the options are first laid out.
-
Options, not instructions
Close monitoring, risk-lowering medicines where they exist, or surgery. Most people are given months, not days, to think. The choice can also be surgery later rather than now.
-
The surgical consultation
If surgery is being considered, a surgical oncologist explains the operation itself, its recovery and its permanent effects, and the family is welcome in the room.
Side by side
Surgery now, or close watching instead?
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four things families tell us, and what is actually true
Nobody is made to have anything. Testing is a choice, and surgery after a positive result is a separate choice. Many carriers choose monitoring instead, and that is a recognised path.
One relative with cancer usually does not raise your risk enough for surgery to be discussed. It is the reason to ask for a family risk assessment. What that assessment finds, and often a gene test, decides what comes next.
The operation lowers the risk of one cancer, in one organ. A small risk remains because a little tissue is always left behind, and other cancers linked to the same gene are not affected. Follow-up continues.
Genetic testing and risk-reducing surgery are both available in Hyderabad. Ask your centre whether the surgeon works alongside a genetics service and a tumour board.
A positive gene test in one person is a result for the whole family. Parents, brothers, sisters and children each have an even chance of carrying the same fault, and each can choose to be tested.
Being straight with you
Who is this not for, and what can this page not tell you?
Risk-reducing surgery does not suit most people who are worried about cancer. If there is no proven gene fault and no very strong family pattern, the risk being removed is small and the harms of the operation are not. A surgeon will say so, and it is the right answer.
It may also not suit some carriers
A person who is unwell with another condition, who has not finished having children, or who is not ready to live with the permanent effects may be better served by monitoring for now. Age matters too. The team will explain when surgery is usually timed for each gene.
What this page cannot do
It cannot tell you your own risk. That comes from your test result, your age and your family history read together by a geneticist. It cannot tell you whether you should have surgery, and it cannot tell you what the operation will cost you, because cover under Aarogyasri, CGHS, ECHS, EHS or a cashless insurer changes the figure completely.
What to do with it
Use it to work out which questions to ask. Which gene fault, which organs it affects, what monitoring would involve, what surgery would involve, and how long you have to decide. Take a family member to the appointment, and take your relative's reports with you.
Questions we are asked
Common questions about risk-reducing surgery
Do I need a gene test before this surgery can be discussed?
Almost always, yes. The gene result is what turns a worry into a measured risk, and surgeons do not remove a healthy organ on worry alone. The exception is a very strong family pattern where no fault can be found, which a genetics team can still assess as high risk. Testing comes first, and it is your choice.
Is this the same as cancer surgery?
No. Cancer surgery removes a tumour that has been found, and its extent is set by where the cancer is. Risk-reducing surgery removes a healthy organ, so there is time to plan, to rebuild where possible, and to choose the timing. There is no urgency of the kind a diagnosis brings.
Will the operation remove all my risk of cancer?
It lowers the risk of one cancer a great deal, but never to nothing. A small amount of tissue always remains, and the same gene fault may raise the chance of other cancers in organs that were not removed. Your follow-up plan is built around that, which is why it continues after surgery.
Can I choose monitoring instead and decide later?
Yes, for most gene faults. Regular scans, scopes or blood tests are a recognised option, and many carriers use them for years before choosing surgery, or never choose it. The exception is a fault where checks cannot find the cancer early, such as CDH1 stomach cancer.
My sister tested positive. Do I have to be tested?
No. Testing is your decision. Because the fault in your family is now known, your test would look for that exact change. Before you decide, a genetic counsellor will talk through what a positive result would mean for you and your children, and what a negative one would not tell you.
Does Aarogyasri or insurance cover an operation on a healthy organ?
Cover varies, and this is the question to settle before anything is booked. Some schemes and insurers cover risk-reducing surgery when a gene fault is documented; others treat it differently from cancer treatment. Bring your scheme card or policy to the first consultation and the helpline will check your specific cover before you travel.
Will my children inherit the same gene fault?
Each child of a carrier has an even chance of inheriting the fault, whichever parent carries it. Testing is usually offered in adulthood, when the person can decide for themselves. A few conditions such as MEN2 and FAP are tested for in childhood because the risk starts young.
How long do I have to decide?
Usually as long as you need. There is no cancer to chase, so the timetable is set by your age, your plans for children and how you feel, not by the hospital. Many people take months. If a team pushes you to book quickly, ask why, and ask what monitoring in the meantime would look like.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Surgery to Reduce the Risk of Breast Cancer
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- NHS — Predictive genetic tests for cancer risk genes
- Cancer Research UK — Inherited cancer genes and increased cancer risk
- NICE — Familial breast cancer: classification, care and managing breast cancer and related risks (CG164)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Holding a gene result nobody has explained?
Send it to us or call the helpline. A surgical oncologist will read it with you and tell you what the next step actually is. One helpline serves every CION centre.